PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsBrimonidine tartrate
Brimonidine tartrate
Download report
Favorite
Novartis Pharmaceuticals
Top OTC Drugs
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
182 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
GlaucomaD005901EFO_0000516H403921411690
Ocular hypertensionD009798EFO_1001069H40.02721221062
Open-angle glaucomaD005902EFO_0004190H40.1181319950
HypertensionD006973EFO_0000537I10172114548
RosaceaD012393—L71—144413
ErythemaD004890HP_0010783L53.9—15219
Intraocular pressureD007429——2——158
Low tension glaucomaD057066EFO_1001022H40.12———5—5
Angle-closure glaucomaD015812————1113
Ocular physiological phenomenaD009799—————123
Show 12 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PresbyopiaD011305—H52.4636——15
Eye diseasesD005128EFO_0003966H44235—111
MiosisD015877HP_0000616H57.03—14——5
CataractD002386HP_0000518H26.9——1—34
ConjunctivitisD003231HP_0000509H10—12—14
Allergic conjunctivitisD003233EFO_0007141H10.44—12—14
Refractive errorsD012030EFO_0003908H52.7121——4
Diabetic retinopathyD003930EFO_0003770——31——3
Dry eye syndromesD015352—H04.12121——3
HyperemiaD006940EFO_0003822—1—2——3
Show 11 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Macular degenerationD008268EFO_0001365H35.30—4———4
SyndromeD013577———2——13
Macular edemaD008269———1——12
Retinal detachmentD012163EFO_0005773H33.2—1——12
Healthy volunteers/patients————1——12
Geographic atrophyD057092———2———2
AtrophyD001284———2———2
MydriasisD015878HP_0011499H57.04—1———1
Hand-foot syndromeD060831EFO_1001893——1———1
Meibomian gland dysfunctionD000080343—H02.8811———1
Show 6 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
FlushingD005483—R23.21———12
PseudophakiaD019591——1————1
Alcohol-related disordersD019973—F101————1
Sjogren-larsson syndromeD016111Orphanet_816E71.31————1
VitrectomyD014821——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HemorrhageD006470MP_0001914R58————22
PterygiumD011625—H11.0————11
Cataract extractionD002387——————11
Diabetes complicationsD048909——————11
Diabetes mellitusD003920HP_0000819E08-E13————11
Corneal diseasesD003316—H18.9————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,203 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,016 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use